It depends. It's on a case-by-case basis, of course. What we have found, and what we know, is that sustained, persistent government-to-government engagement and industry-to-industry advocacy are the best path forward to overcoming these barriers when they arise, as well as Canada's championing of risk-based scientific assessments.
On May 15th, 2023. See this statement in context.